Ads
related to: armp stock- The Long View
Download Now to Explore Four
Megatrends on Our Investment Radar
- Capital Ideas Webinars
Our Brightest Minds Answer
Your Biggest Questions. Tune In.
- Subscribe to Newsletter
Read Our Latest Investment Thinking
In Your Inbox Each Week.
- Capital Ideas Podcast
Connect With the Minds of
Our Portfolio Managers
- The Long View
Search results
Armata Pharma (ARMP) Stock Surges 130% in a Month: Here's Why
Zacks via Yahoo Finance· 9 months agoArmata Pharma (ARMP) stock skyrockets 130% in a month due to encouraging progress of the company's...
Armata Pharmaceuticals, Inc. (ARMP) Now Trades Above Golden Cross: Time to Buy?
Zacks via Yahoo Finance· 9 months agoArmata Pharmaceuticals, Inc. (ARMP) reached a significant support level, and could be a good pick...
Armata Pharmaceuticals, Inc. (ARMP) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Zacks via Yahoo Finance· 1 year agoArmata Pharmaceuticals, Inc. (ARMP) witnesses a hammer chart pattern, indicating support found by...
Armata Pharmaceuticals, Inc. (ARMP) Reports Q2 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoArmata Pharmaceuticals, Inc. (ARMP) delivered earnings and revenue surprises of 0% and 98.21%,...
Armata Pharmaceuticals Inc (ARMP) Reports Q3 2023 Financial Results and Corporate Updates
GuruFocus.com via Yahoo Finance· 6 months agoArmata Pharmaceuticals Inc (ARMP) announced a Q3 2023 loss from operations of $(10.3) million,...
Armata Pharmaceuticals Inc (ARMP) Earnings: Navigates Through R&D to Narrow Losses
GuruFocus.com via Yahoo Finance· 2 months agoRevenue: Q4 grant revenue of $1.5 million, surpassing the estimated $1.071 million. Net Loss: Q4 net...
Investors Cheer Armata Pharma's Encouraging Data From Lung Infection Candidate
Benzinga via Yahoo Finance· 1 year agoArmata Pharmaceuticals Inc (NASDAQ: ARMP) announced positive topline results from the completed...
Ad
related to: armp stock